• Passa al contenuto principale
BC

biochimica clinica

it_IT Italian
it_IT Italian en_US English
  • Home
  • Casi clinici
  • Ahead of print e Ultimo Fascicolo - Accedi per visualizzare gli articoli
  • Archivio BC fino a 2024
  • Sottometti un articolo
  • Norme Autori
  • Cerca

RASSEGNE - Reviews

Volume:

Biochimica Clinica 2022; 46(3) S031-S041

Pubblicato on-line:

Maggio 10, 2022

DOI:

10.19186/BC_2022.030

Scarica in PDF:

Gli esami di laboratorio nel percorso di procreazione medicalmente assistita
Laboratory tests in assisted reproductive technologies

AUTORI

Margherita Ceccobelli, Brunella Pugliese, Sandro Gerli
Dipartimento di Medicina e Chirurgia, Clinica Ostetrica e Ginecologica, Centro di Procreazione Medicalmente Assistita, Azienda Ospedaliera di Perugia, Università di Perugia.

ABSTRACT

Infertility is defined as the failure to achieve pregnancy after 12/24 months of regular unprotected sexual intercourse. Clinical and laboratory evaluations are required to find out the apparent determinants of infertility problem. Accurate diagnosis and effective therapy can facilitate achievement of fertility goals in many couples treated for infertility.Laboratory monitoring of the infertile couple include the female endocrinological assessment to evaluate the ovarian cycle physiology, the ovarian reserve, the thyroid function and others.Assisted reproductive technologies have become a common and accepted form of clinical care benefiting people of reproductive age who are subfertile or infertile. Traditional monitoring of ovarian hyperstimulation during assisted reproductive technologies treatment has included transvaginal ultrasonography plus the measurement of serum estradiol and progesterone levels to ensure safe practice by reducing the incidence and severity of ovarian hyperstimulation syndrome whilst achieving the good ovarian response needed for assisted reproduction treatment. The need for combined monitoring (using ultrasonography and serum hormone determination) during ovarian stimulation in assisted reproduction is controversial.

BIBLIOGRAFIA

HOME
PRIVACY POLICY
5x1000 Docemus

LOGO SIBioC

EDITORE RESPONSABILE
Alberto Oliaro

EDITORIAL SECRETARY
Edizioni Minerva Medica S.p.A.
Corso Bramante 83-85, 10126 Torino
T +39 011 678282
journals.dept@minervamedica.it

Designed by Biomedia srl
© 2025 SIBioC
P. IVA IT 06484860967